in the urinary excretion of glucose, amino acids, electrolytes (particularly Na + , K + and Ca 2+ ) and low molecular weight proteins (ATSDR, 2008; Jarup, 2002) . A growing volume of evidence indicates that adverse renal effects of Cd can result from even low levels of Cd exposure and that women, children and individuals with confounding health conditions, such as diabetes, may be especially susceptible (Akesson et al., 2005; ATSDR, 2008; Jarup, 2002; Navas-Acien et al., 2009; Nawrot et al., 2008; Satarug et al., 2003; Suwazono et al., 2010; Thomas et al., 2009) .
Evolving View of the Mechanisms of Cadmium Nephrotoxicity. While the general effects of Cd on proximal tubule function have been well-documented, the specific molecular mechanisms that underlie these effects are not yet fully understood. It should be emphasized that the current uncertainties are not merely due to a lack of attention or information. Even though it is fashionable for authors of these types of reviews (including these authors) to state that "little is known" about the mechanisms of Cd toxicity, such statements are not completely true. In reality, a great deal is actually known regarding the basic molecular mechanisms by which Cd can alter renal epithelial cell function (for reviews see Jarup, 2002; Prozialeck, 2000; Thevenod, 2009 ). The problem is that much of this information has been generated from studies on renal epithelial cells in culture, and the relevance of many of these findings to the nephrotoxic effects of Cd in vivo remain unclear. This issue has been complicated by the unusual toxicokinetics of Cd in the body and by the ability of Cd to interact with a vast array of biological molecules. When using in vitro models, it is difficult, if not impossible, to mimic the conditions under which renal epithelial cells are exposed in vivo and to sort out the relevant biological effects from the irrelevant. However, while the problems of identifying the mechanisms of Cd toxicity have certainly been formidable, they have not been insurmountable. By applying modern techniques of cellular and molecular biology to the study of in vivo model systems, investigators have, in fact, managed to obtain new insights into the molecular basis of Cd-induced proximal tubular injury.
The purpose of this commentary is to highlight some of the most significant findings in this evolving field of research. This will not be a comprehensive review, but will focus on recent in vivo findings showing that the early stages of Cd nephrotoxicity involve specific changes in proximal tubule cell-cell adhesion, cellular signaling cascades and autophagic responses that occur before the onset of necrosis or apoptosis of proximal tubule cells. We will also highlight recent findings suggesting that it may be possible to detect these early stages of Cd toxicity through the use of improved biomarkers, such as kidney injury molecule-1 (Kim-1). In discussing these topics, we will consider aspects of the toxicokinetics of Cd in vivo and some of the key pathologic events that are associated with the onset of proximal tubule injury. Finally, some of the potential therapeutic and mechanistic implications of these findings will be considered. In
Toxicokinetics of Cd in Vivo.
Any discussion of the actions of Cd in the kidney must begin with consideration of the forms of Cd that exist under physiologic conditions and the distribution of these forms of Cd within the body. These topics have been the subject of several excellent reviews (Bridges and Zalups, 2005; He et al., 2009; Jin et al., 1998) . However, they have often been overlooked in many of the in vitro studies on the cytotoxic actions of Cd, a fact that has greatly complicated the extrapolation of in vitro mechanistic findings to the actions of Cd in the whole kidney.
With respiratory exposure, Cd is efficiently absorbed from the lung; up to 40-60% of inhaled Cd reaches the systemic circulation. With oral exposure, the absorption of Cd from the gastrointestinal tract is considerably lower (only 5-10%). However, with long term exposure, even this low level of absorption from the gastrointestinal tract can lead to systemic accumulation of Cd and subsequent toxicities. The gastrointestinal absorption of Cd may be substantially higher in individuals with low body stores of iron, which is a factor that could contribute to individual variations in sensitivity to Cd exposure.
the Cd-metallothionein complex is non-toxic to most organs, it can be filtered at the glomerulus and taken up by the epithelial cells of the proximal tubule. In this situation, Cd-metallothionein can have the paradoxical effect of facilitating the delivery of Cd from the liver to the kidney, and it has been suggested that Cd-metallothionein may actually mediate some of the toxic effects of Cd in proximal tubule (Klaassen and Liu, 1997) .
However, a great deal of evidence indicates that it is actually ionic Cd (Cd   +2   ) , not Cdmetallothionein, that injures proximal tubule epithelial cells (Goyer et al., 1989; Klaassen et al., 2009) . The fact that metallothionein-null animals are sensitive to Cd-induced proximal tubule injury provides compelling evidence that Cd-metallothionein does not play a critical role in directly mediating the nephrotoxic effects of Cd (Liu et al., 1998) .
One especially important aspect of Cd disposition that has been overlooked frequently is that essentially all Cd in the plasma is bound to proteins or other molecules. The circulating Cd may either be tightly bound to specific metal binding proteins such as metallothionein (Klaassen et al., 2009; Klaassen and Liu, 1997) , or may be loosely associated with molecules, such as albumin, amino acids or low molecular weight sulfhydryl compounds such as glutathione or cysteine (Bridges and Zalups, 2005; He et al., 2009) . These interactions of Cd with proteins and low molecular weight compounds in plasma have greatly complicated efforts to identify the molecular mechanisms by which Cd is taken up by proximal tubule epithelial cells in vivo. Various studies to address this issue have shown that Cd can enter proximal tubule cells through a variety of mechanisms (He et al., 2009 in a process that involves megalin-medicated transport at the brush border (Klaassen et al., 2009; Squibb and Fowler, 1984) . In addition, there is evidence for the uptake of lower molecular weight Cd-thiol conjugates (cysteine and glutathione) by proximal tubule cells (Bridges and Zalups, 2005) . However, it is also important to note that the interaction between Cd and low molecular weight thiols is of a low enough affinity that Cd could dissociate from the thiol and bind to molecules on the cell surface and, in some cases, enter the cell. Indeed, there is evidence that Cd can enter renal tubular cells through a variety of channels and transporters for ions such as Ca 2+ , Fe 2+ and Zn 2+ (Bridges and Zalups, 2005; He et al., 2009 ). Nebert and coworkers have recently provided compelling evidence that the ZIP8 family of metal ion transporters play especially important role in the cellular uptake of Cd in the kidney (He et al., 2009) .
Taken together, these findings suggest that with typical patterns of exposure, multiple mechanisms probably contribute to the uptake of Cd in the proximal tubule in vivo.
Another important consideration relates to the concentrations of Cd that are typically achieved in vivo (for review see Prozialeck and Edwards, 2010) . The blood levels of Cd in non-exposed populations are typically less than 0.5 μ g/L. Blood levels higher than 1.0μg/L are generally indicative of Cd exposure; levels higher than 5μg/L are considered hazardous. Urinary levels of Cd in non-exposed populations are normally below 0.5μg/g creatinine; values above 1-2 μ g/g are indicative of exposure or elevated body burden. The critical urinary Cd concentration that is associated with the onset of renal injury is usually about 2-10 μ g/g creatinine, which corresponds to a renal cortical
Cd concentration of about 150-200 μ g/g tissue (Jarup, 2002; Roels et al., 1979) . These
This article has not been copyedited and formatted. The final version may differ from this version. In considering the use of in vivo models to study Cd nephrotoxicity, investigators must balance the need to be able to do the studies in a reasonably short time frame with the need to replicate the toxicokinetics of the long-term, low-level patterns of exposure that are common in humans. For example, even though humans are typically exposed to dietary Cd over many years or decades, it is simply not possible or practical to replicate this type of exposure in species such as rats or mice. Since, these species have shorter life spans, and for many practical reasons, exposure levels used in animal studies are usually higher, but shorter in duration, than those used in humans.
This article has not been copyedited and formatted. The final version may differ from this version. Cd is a classic cumulative nephrotoxicant. With higher levels of exposure, nephrotoxic effects occur more quickly than with lower levels of exposure. In commonly used animal models, there is a linear inverse relationship between the dose of Cd and the time of exposure causes onset of proximal tubule injury (i.e. doubling the dose produces effects in ½ the time) . However, higher doses of Cd can cause injury to organs other than the kidney, particularly the liver and gonads. For nephrotoxicity studies, one of the most useful approaches has involved the subcutaneous administration of moderate doses of Cd (0.4 -0.8 mg/kg/day) for periods ranging from 4-12 weeks. However, even with this approach, slight differences in treatment protocols and methodologies can complicate comparisons of results from different laboratories.
To address some of the key issues, our own research groups have been utilizing a treatment protocol that involves the subcutaneous administration of Cd to rats (0.6 mg/kg, 5 days per week for up to 12 weeks) (Prozialeck and Edwards, 2010; Prozialeck et al., 2007; Prozialeck et al., 2009a; Prozialeck et al., 2009b) . This has been a widely It has long been recognized that high nephrotoxic doses of Cd can cause proximal tubule necrosis. However, it has also been apparent that early manifestations of Cdinduced proximal tubule dysfunction occur well before the onset of necrosis. In the 1990's, several investigators (Hamada et al., 1991; Tanimoto et al., 1993; Tanimoto et al., 1999; Yan et al., 1997) published results showing that the early stages of Cd nephrotoxicity were associated with an increase in the number of apoptotic cells in the proximal tubule. In each of these studies, there was no significant evidence of necrotic injury at the time that apoptosis was observed. The studies by Tanimoto were especially noteworthy because the authors also identified proximal tubule cells that appeared to be proliferating as part of the response to apoptotic injury. In another study, Aoyagi et al. (2003) noted an increase in the number of apoptotic cells in the renal cortex of Cd treated rats after 4 and 5 weeks of exposure, but that the level of apoptotic labeling was much less pronounced after 6 and 8 weeks of exposure. In more recent studies from our laboratory (Prozialeck et al., 2009a) , we also found that Cd caused a low level of apoptosis in the proximal tubules of sub-chronically exposed rats. However, the onset of apoptosis appeared to occur after kidney-injury molecule-1 (Kim-1)-dependent tissue repair processes had already been activated suggesting that Cd can produce significant changes in the cells before the onset of apoptosis. In a very recent study utilizing an acute (only 5 days), intraperitoneal model of Cd exposure in the rat, Chargui et al. There are several aspects of these studies that merit special attention. First, in all of the studies in which apoptotic cells were identified, the onset of apoptotic cell death appeared to coincide with the onset of proximal tubule dysfunction, as evidenced by polyuria and/or proteinuria. However, it is also noteworthy that in each of these studies, the number of proximal tubule cells that were actually undergoing apoptosis were quite low (i.e. well below 5%). The vast majority of proximal tubular cells were largely unaffected by Cd and/or appeared to dedifferentiate and proliferate as part of the repair process. The fact that only a small percentage of renal cells are being affected by Cd could greatly complicate efforts to identify the biochemical mechanisms by which the effects are occurring because it can be technically difficult to identify any possible Cdinduced biochemical changes in a few cells that are located in a sea of cells that are not being affected by Cd. However, it is also apparent that Cd causes some sort of injury that triggers this low level of apoptosis. In this context, the studies by Prozialeck at al.
(2009a) and Chargui (2011) are especially significant in that they clearly show that Cd is producing detectable effects, such as upregualtion of Kim-1 and induction of autophagy, in proximal tubule cells before there is evidence of apoptosis or proximal tubule dysfunction.
The key question that has yet to be resolved is, how is Cd causing the initial injury to proximal tubule cells? Studies over the past 10 years have yielded some insights. In vivo, involves the disruption of cadherin-medicated cell-cell adhesion (for reviews see Prozialeck, 2000; Prozialeck et al., 2003; Prozialeck and Edwards, 2007) . The cadherins represent a family of calcium-dependent cell adhesion molecules that are usually localized at adherens junctions in epithelial cells (Prozialeck and Edwards, 2007) . The extracellular domain of the cadherin contains Ca-binding sites and the adhesive regions. The intracellular domain is bound to β-catenin which is bound to α-catenin, which links the entire complex to the actin cytoskeleton. β-catenin also functions as a regulator of gene expression through the wingless/ Wnt nuclear signaling pathway (Prozialeck and Edwards, 2007; Thevenod, 2009 ). When β -catenin is released from the junctional complex into the cytosol, it may either be targeted for proteosomal degradation in a process that involves the adenomatous polyposis coli (APC) gene product and the serine/threonine kinase GSK-3β, or it can enter the nucleus, where it can bind to TCF-LEF-1 transcription factors and alter the expression of genes involved in apoptosis and cell-cycle control (Prozialeck and Edwards, 2007; Thevenod et al., 2007; Thevenod, 2009 ).
This article has not been copyedited and formatted. The final version may differ from this version. The finding that the cadherins are targets of Cd toxicity stemmed from observations by Prozialeck and Niewenhuis (1991) who found that exposing cultured renal epithelial cells to 5-20 μ M Cd for 1-4 hours caused the cells to separate from each other and change from epitheloid to rounded, an effect that coincided with the loss of E-cadherin from the cell-cell contacts. Subsequent studies showed that Cd had similar effects on Eand N-cadherin junctions in many types of epithelial cells and on VE-cadherin junctions in vascular endothelial cells (Prozialeck, 2000) . The ability of Cd to disrupt cadherindependent cell-cell junctions has been confirmed by many other laboratories and is now generally accepted as one of the primary actions of Cd on epithelial cells (for review, see Prozialeck and Edwards, 2007) . It is also noteworthy that even though Cd was the first nephrotoxic agent that was found to disrupt cadherin-mediated cell-cell adhesion, it is now recognized that this is a primary effect of many nephrotoxic substances including mercury, bismuth and aminoglycoside antiobiotics (for reviews see Parrish and Prozialeck, 2010; Prozialeck and Edwards, 2007 Prozialeck, 2000) , primarily express E-cadherin, which is the main cadherin expressed in most types of epithelial cells. However, when we tried to visualize E-cadherin in rat kidney, we found that the predominant cadherin in the proximal tubule was not Ecadherin but N-cadherin (Prozialeck et al., 2003; Prozialeck et al., 2004) . In addition, the labeling along the basolateral surface was much more diffuse than in the control samples. It is important to emphasize that these changes in N-cadherin localization were widespread and were readily apparent in all of the samples from the Cd-treated animals that were examined. Other investigators have shown that at about this same stage of inquiry significant changes in the microvilli and actin cytoskeleton (Sabolic et al., 2001; Sabolic et al., 2006) . Together, these findings suggest that the cadherins or their associated catenins or cytoskeletal elements may be key early targets of Cd toxicity.
Since the cadherins play a critical role in establishing and maintaining the epithelial polarity that is essential for the normal functioning of the proximal tubule (Molitoris and Cd-treated animal, the Na + , K + -ATPase labeling is present over the entire cell surface and, in some areas, appears on the apical surface. These changes in Na+, K+, ATPase localization are similar to those described previously by Sabolic et al. (2006) . These findings suggest that Cd-induced changes in cadherin dependent cell-cell adhesion may result in changes in epithelial polarity that are similar to those that have been described in ischemic kidney injury (for reviews, see Molitoris and Marrs, 1999) . differentially affected the expression of E-cadherin, VE-cadherin and N-cadherin. There were no effects on the expression of E-cadherin or VE-cadherin at either 6 weeks or 12 weeks, or N-cadherin at 6 weeks. However, at 12 weeks, the expression of N-cadherin mRNA by about 50%. The fact that the expression of N-cadherin changes in response to Cd exposure, while the expression of E-cadherin and VE-cadherin do not, is consistent with our findings that N-cadherin is a target of Cd toxicity. Moreover, the fact that there is no change in N-cadherin mRNA or protein levels (protein data not shown)
at 6 weeks, a time at which changes in the localization of N-cadherin in the proximal tubule are readily apparent, suggests that the initial effects of Cd involve either direct effects on N-cadherin or its associated molecules, or actions on one of the signaling pathways that regulate the function of N-cadherin.
It is also noteworthy that Cd had no effect on the expression of Another interesting finding from the mRNA analyses is that even though Cd caused a marked increase in the expression of metallothionein, it had little or no effect on the Cd and Oxidative Stress. One final aspect of Cd nephrotoxicity that merits special discussion is the role of oxidative stress in the pathophysiologic processes. Cd is not a Fenton metal, and as a stable divalent cation, it does not undergo redox cycling.
However, Cd is clearly able to induce oxidative stress, and this mechanism has long been thought to play a role in Cd-induced kidney injury (for reviews, see Gobe and Crane, 2010; Liu et al., 2009) . Rather than directly causing oxidative stress, Cd appears to act indirectly by binding to intracellular thiols such as glutathione, and/or interfering with the actions of various enzymes that protect against oxidative stress. Through these indirect mechanisms, Cd can greatly amplify the actions of normal oxidative processes within the cell, which results in oxidative stress. While oxidative stress has long been thought of as a relatively non-specific mechanism of cellular injury, it is now appreciated that oxidative stress, particularly at low-moderate levels, may actually trigger the activation of specific oxidative signaling pathways Thevenod, 2009) . It is noteworthy that many of these so called oxidative signaling pathways have also been shown to be modulated by Cd exposure (Thevenod, 2009) .
However, at the present time, the cause-effect relationship between the signaling effects of Cd and the development of oxidative stress are not clear. Our own studies (Prozialeck et al., 2003 , along with data in Table 1 Cd and Glomerular Injury. While the proximal tubule is the primary target of Cdinduced kidney injury, there is evidence that Cd, particularly at higher levels of exposure, can also affect the glomeruli (Xiao et al., 2009) . Changes in classic markers of glomerular dysfunction such as serum or urinary creatinine are generally not seen during the early or mild stages of Cd-induced kidney injury (Prozialeck and Edwards, 2007; Prozialeck et al., 2009a) . However, several investigators have reported associations between Cd exposure and alterations (either increased or decreased) creatinine clearance (Bernard, 2004; Mueller et al., 1998; Navas-Acien et al., 2009; Trzcinka-Ochocka et al., 2004) . Some studies have also shown increased urinary excretion of albumin during the early stages of Cd toxicity (Haswell-Elkins et al., 2008; Mueller, 1993; Mueller et al., 1998) , which is classically interpreted as a marker of glomerular damage. Navas-Acien et al. (2009) Pb. At present, the relative contributions and relationship of glomerular injury and proximal tubule injury to these reported increases in urinary albumin excretion remain unclear.
Implications for Biomonitoring and Therapeutic Interventions. The finding that the early toxic effects of Cd in the proximal tubule may involve relatively specific changes in cell-cell adhesion and cellular signaling cascades has very important implications for biomonitoring Cd-exposed populations and for the potential treatment of Cd nephrotoxicity. The monitoring of at risk populations for early signs of Cd nephrotoxicity has posed special challenges (for reviews, see (Bernard, 2004; Prozialeck and Edwards, 2010) . As a result of the tendency of Cd to accumulate in tissues such as the liver and kidney, monitoring of blood and urinary Cd often provides an incomplete reflection of the level of exposure and kidney disease. Because of these problems, investigators have utilized various biomarkers to characterize the severity of Cd-induced kidney disease. Some of the urinary biomarkers that have been used for this purpose include the Cd-binding protein metallothionein, low molecular weight proteins such as β -2 microglobulin, proximal tubule derived enzymes such as NAG and even Cd itself (Bernard, 2004) . While these markers have been used to monitor Cd toxicity in humans and experimental animals, several problems remain. Most significantly these current markers only identify relatively late stages of Cd-induced kidney injury. By the time these markers appear in the urine, the injury to the kidney is generally considered to be irreversible and untreatable. Thus, there is a need for better early biomarkers of Cdinduced kidney injury.
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One novel marker that has shown exceptional promise in preclinical studies is kidney injury molecule-1 (Kim-1). Kim-1 is a transmembrane protein that is not detectable in normal kidney but is expressed at high levels in the proximal tubule after ischemic or toxic injury (Vaidya et al., 2008) . Kim-1 acts as a regulator of cell adhesion and endocytosis in regenerating cells of the injured tubule as they reform a functional epithelial barrier. This process is associated with the proteolytic cleavage of the ectodomain of Kim-1 into the urine. The ectodomain is stable in urine and has been shown to be a sensitive marker of renal injury induced by a variety of agents (Vaidya et al., 2008) .
In studies utilizing a rat model of Cd-induced kidney injury, Kim-1 outperformed traditional urinary markers Prozialeck et al., 2009a; Prozialeck et al., 2009b) . Kim-1 was detected in the urine 4-5 weeks before onset of proteinuria, and 2-5 weeks before the appearance of other markers such a metallothionein and CC-16. Other studies showed that the Cd-induced increase in Kim-1 expression occurred at a time when there was little or no evidence of either necrosis or apoptosis of proximal tubule epithelial cells (Prozialeck et al., 2009a) . The fact that Kim-1 can be detected at a time before lethal injury to proximal tubule epithelial cells has occurred may be especially significant. Perhaps, with earlier detection via Kim-1, it may be possible to reverse, or at least more effectively treat, Cd-induced kidney injury. In light of this possibility, studies on the utility of Kim-1 as marker of Cd toxicity in humans are certainly warranted.
This article has not been copyedited and formatted. The final version may differ from this version. shown that Kim-1 expressing cells "phagocytize" debris from necrotic and apoptotic cells through the binding of Kim-1 to phosphatidylserine residues on damaged cells.
However, it is unclear how these findings relate to the action of Cd in the proximal tubule. At the time Kim-1 is expressed in the proximal tubule, there is no evidence of necrosis and only modest evidence of apoptosis (Prozialeck et al., 2009a) . At this same time, there are widespread alterations in the localization of N-cadherin (Prozialeck et al., 2003) . Perhaps, the loss of N-cadherin mediated cell-cell adhesion is a key event in triggering the expression of Kim-1. Moreover, it is unclear how these disruption of cellcell adhesion and the expression of Kim-1 might be related to the onset of oxidative stress and/or the disruption of cellular signaling cascades. Additional studies are needed to resolve these issues.
An important caveat that needs to be considered is that even with the use of a very sensitive biomarkers such as Kim-1, Cd exposure is not evident until some sort of toxic injury has occurred. One of the more intriguing aspects the studies summarized here is that some of the findings suggest that it may be possible to detect evidence of Cd even halt these pathophysiologic processes before they become irreversible. It is our hope that this review will serve as a framework for future studies in this area.
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